Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats

Pharmacology Biochemistry and Behavior

Volumn 85, Issue 3, 2006, Pages 507-513

  Wright Jr , M Jerry ^a   Vann, Robert E ^a   Gamage, Thomas F ^a   Damaj, M Imad ^a   Wiley, Jenny L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Dextromethorphan; Dextrorphan; Discriminative stimulus; Nicotine; Receptor subtype

Indexed keywords

BUNGAROTOXIN RECEPTOR; DEXTROMETHORPHAN; DEXTRORPHAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINE; NICOTINE RECEPTOR BETA2; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3BETA4; NICOTINIC RECEPTOR ALPHA4BETA2; RECEPTOR SUBTYPE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; DEXTROMETHORPHAN; DEXTRORPHAN; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NICOTINE; RATS; RATS, LONG-EVANS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; SELF ADMINISTRATION;

RATTUS;

EID: 33846190699     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.09.020     Document Type: Article

References (34)

1. Aceto M.D., Martin B.R., Uwaydah I.M., May E.L., Harris L.S., Izazola-Conde C., et al. Optically pure (+)-nicotine from (+/-)-nicotine and biological comparisons with (-)-nicotine. J Med Chem 22 2 (1979) 174-177
2. Chou Y.C., Liao J.F., Chang W.Y., Lin M.F., and Chen C.F. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Res 821 (1999) 516-519
3. Damaj M.I., Glassco W., Dukat M., and Martin B.R. Pharmacological characterization of nicotine-induced seizures in mice. J Pharmacol Exp Ther 291 (1999) 1284-1291
4. Damaj M.I., Flood P., Ho K.K., May E.L., and Martin B.R. Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. J Pharmacol Exp Ther 312 (2005) 780-785
5. Denoble V.J., and Mele P.C. Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone. Psychopharmacology 284 (2006) 266-272
6. Di Marco A., Yao D., and Laufer R. Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes. Eur J Biochem 270 (2003) 3768-3777
7. Ebert B., Thorkildsen C., Andersen S., Christrup L.L., and Hjeds H. Opioid analgesics as noncompetitive N-methyl-d-aspartate (NMDA) antagonists. Biochem Pharmacol 56 (1998) 553-559
8. France C.P., Snyder A.M., and Woods J.H. Analgesic effects of phencyclidine-like drugs in rhesus monkeys. J Pharmacol Exp Ther 250 (1989) 197-201
9. 3H] dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-d-aspartate receptor-cation channel. Mol Pharmacol 41 (1992) 134-146
10. Gavend M., Mallaret M., Dematteis M., and Baragatti G. Discriminative stimulus properties of dextromethorphan in rats. Biomed Pharmacother 49 (1995) 456-464
11. Glick S.D., Maisonneuve I.M., Dickinson H.A., and Kitchen B.A. Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats. Eur J Pharmacol 422 (2001) 87-90
12. Glick S.D., Maisonneuve I.M., and Kitchen B.A. Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors. Eur J Pharmacol 448 (2002) 185-191
13. Grabus S.D., Martin B.R., Brown S.E., and Damaj M.I. Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology 184 (2006) 456-463
14. Hernandez S.C., Bertolino M., Xiao Y., Pringle K.E., Caruso F.S., and Kellar K.J. Dextromethorphan and its metabolite dextrorphan block α3β4 neuronal nicotinic receptors. J Pharmacol Exp Ther 293 (2000) 962-967
15. Holtzman S.G. Discriminative stimulus effects of dextromethorphan in the rat. Psychopharmacology 116 (1994) 249-254
16. Le Foll B., and Goldberg S.R. Nicotine as a typical drug of abuse in experimental animals and humans. Psychopharmacology 184 (2006) 367-381
17. Mariathasan E.A., and Stolerman I.P. Discrimination of agonist-antagonist mixtures: experiments with nicotine plus mecamylamine. Behav Pharmacol 4 (1993) 555-561
18. Maskos U., Molles B.E., Pons S., Besson M., Guiard B.P., Guilloux J.P., et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436 7047 (2005) 103-107
19. Murray T.F., and Leid M.E. Interaction of dextrorotary opioids with phencyclidine recognition sites in rat brain membranes. Life Sci 34 (1984) 1899-1911
20. National Research Council. Guide for the care and use of laboratory animals. 7th ed. (1996), National Academy Press, Washington, DC
21. Nicholson K.L., Hayes B.A., and Balster R.L. Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys. Psychopharmacology 146 (1999) 49-59
22. Papke R.L., Sanberg P.R., and Shytle R.D. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J Pharmacol Exp Ther 297 (2001) 646-656
23. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., et al. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391 (1998) 173-177
24. Shoaib M., Zubaran C., and Stolerman I.P. Antagonism of stimulus properties of nicotine by dihydro-beta-erythroidine (DHbetaE) in rats. Psychopharmacology 149 (2000) 140-146
25. Shoaib M., Gommans J., Morley A., Stolerman I.P., Grailhe R., and Changeux J.P. The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42 (2002) 530-539
26. Steinberg G.K., Kunis D., DeLaPaz R., and Poljak A. Neuroprotection following focal cerebral ischemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile. Neurol Res 15 (1993) 174-180
27. Szekely J.I., Sharpe L.G., and Jaffe J.H. Induction of phencyclidine-like behavior in rats by dextrorphan but not by dextromethorphan. Pharmacol Biochem Behav 40 (1991) 381-386
28. Tallarida R.J., and Murray R.B. Manual of pharmacologic calculations with computer programs. 2nd ed. (1987), Springer-Verlag, New York
29. * receptors: sufficient for reward, tolerance, and sensitization. Science 306 5698 (2004) 1029-1032
30. Tortella F.C., and Musacchio J.M. Dextromethorphan and carbetapentane: centrally acting non-opioid antitussive agents with novel anticonvulsant properties. Brain Res 383 (1986) 314-318
31. Wiley J.L., James J.R., and Rosecrans J.A. Discriminative stimulus properties of nicotine: approaches to evaluating potential nicotinic receptor agonists and antagonists. Drug Dev Res 38 (1996) 222-230
32. Wiley J.L., Harvey S.A., Balster R.L., and Nicholson K.L. Affinity and specificity of N-methyl-d-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats. Psychopharmacology 165 (2003) 378-385
33. Wu D., Otton S.V., Kalow W., and Sellers E.M. Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat. J Pharmacol Exp Ther 274 (1995) 1431-1437
34. Zakharova E.S., Danysz W., and Bespalov A.Y. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats. Psychopharmacology 179 (2005) 128-135